Business
Disrupt Europe? – Switzerland Opens the Flood Gates to Ship Cannabis All Around the World
At the moment, there is an aggressive revolution going on in Switzerland. The nation is preparing for what will probably be the most disruptive recreational trial in Europe.
According to Forbes, starting on the 1st of August, Switzerland will allow medicinal marijuana patients to obtain prescriptions straight from their doctors instead of having to apply for authorization from the FOPH (Federal Office of Public Health). The new regulations effectively make medical marijuana legal in the nation and permit the export of medical marijuana for commercial purposes. However, the products can not have a THC content of more than 1%.
A lot of other important events are taking place in the meantime. In particular, the government is set to eliminate the restriction that doctors who prescribe cannabis do so only with specific permission.
The Swiss Federal Council, a seven-member administrative body that acts as the nation’s joint head of state and federal government, began deliberations on amending the nation’s Narcotics Act this past Wednesday.
Both types of marijuana, i.e., the recreational and the medical kind, have been prohibited in Switzerland since 1951. By changing the federal Narcotics Act in this manner, doctors in Switzerland will be permitted to prescribe marijuana more or less as free as they see fit. Presently, there are about 3,000 approvals handed out every year to treat patients with neurological diseases, MS, and cancer.
As a result of this, cannabis will become just a regulated narcotic as it is with Germany across the DACH border (DACH is an acronym for Switzerland, Germany, and Austria, which are in a special trading alliance). The three countries are also nearly aligned culturally, beginning with a language in common.
THE ODD TWIST FROM THE SWISS
Since we are dealing with marijuana, there is always going to be a twist in all of this, regardless of where the reform is taking place.
On a positive note, the growing, producing, and selling of medical marijuana will be approved on the federal level for the very first time. Export for commercial purposes will be allowed. The rules for imports, however, are not as clear ( though it is not likely that anyone will restrict imports of the EU-GMP medical type).
This can hardly be called revolutionary, considering that Switzerland’s nearest trading neighbor to the north, Germany, moved to do this four years ago. In fact, the first cannabis grown in Germany is only now making its way to pharmacies there. Meanwhile, growing cannabis for personal use is, of course, still prohibited.
Now, here is the weirdest, if not most suspicious twist of all.
In the coming months, Switzerland will also start an unusual recreational trial. The trial will see that pharmacies in Switzerland will be able to sell high-THC commodities to anybody who has the money to pay for it so long as they are over 21 years old.
The solution of the Swiss is not as cynical as that of the Dutch, who permitted insurers to stop paying back medical marijuana claims almost immediately after Germany amended the law to say that public insurers did so back in 2017.
That being said, the experiment is definitely taking place at a fascinating time, just on the other side of the border. The conversation by German federal lawmakers on which direction the marijuana legalization winds would blow as a result of the election in late September was one of the most crowded panels at the latest ICBC in Berlin.
Everywhere you go, cannabis reform is a sore point, including, and maybe even specifically, in Germany, which has by far the most prominent medical marijuana market in Europe. It is also the most influential. Cannabis reform is a fiery issue just about everywhere. Furthermore, it is exceedingly improbable that any reformers in Germany will pass up the chance to inform German lawmakers, that are still extremely reluctant of what the Swiss are currently doing.
EFFORTLESS ACCESS…
The continuing, hardline response of the government to any kind of cannabis reform is one of the biggest pet peeves in the DACH region (which, of course, also includes Austria). An illustration of this is the recent catastrophe that Lidl, one of the biggest retailers in the world, had in Munich.
As a matter of fact, the recent absurd prosecutions, especially in Germany where hemp tea is a hot topic, and the absence of reform are likely to drive at least some reform in Germany. The Swiss appeared poised to lead Europe, if not the DACH, in all things both recreationally and medically reform related or at least minded. Add to the equation general ease of restrictions in Switzerland, along with what appears to be an already slicker if not more reasonable plan for manufacture and cultivation, and the Swiss looked ready and willing to take the lead.
The alteration is not only welcome but also long overdue, according to Dr. Francis Scanlan, CEO of Cloud 9 Switzerland, a life sciences business that is preparing to introduce its own THC Swiss chocolate bar after breaking new ground with his product being the very first CBD edible to commence sales in Dubai.
This is a very sensible, if progressive, action in reaction to the widespread acknowledgment of cannabis as a legitimate treatment that genuinely benefits patients and has the potential to save healthcare costs while also producing tax income, according to Scanlan. “What is taking place in Switzerland for medical cannabis on prescription and our new recreational Pilot Program is very impressive and should be considered as a sensible way to regulate a plant that has been demonized around the world for far too long,” the statement reads.
BOTTOM LINE
The new regulation in Switzerland puts an end to the ban on cannabis that had existed since the year 1951. The regulation will legalize both recreational and medical marijuana completely in the country. Also, patients that are already on marijuana medication and potential medical cannabis patients will not have trouble accessing the marijuana as, under the new law, doctors will not need to seek permission before prescribing cannabis. The law also sees Switzerland being the most progressive of DACH and places them in a leading position.
Business
Jio’s 1,600-Satellite LEO Constellation Gets Technical Green Light
Reliance Jio has crossed a significant milestone in its space connectivity ambitions after its proposal to deploy a Low Earth Orbit (LEO) satellite constellation of around 1,600 satellites received a positive technical assessment from the Indian National Space Promotion and Authorisation Centre (IN-SPACe).
The evaluation, conducted jointly by IN-SPACe, the Indian Space Research Organisation (ISRO), and the Wireless Planning and Coordination (WPC) wing of the Department of Telecommunications, reportedly concluded that Jio’s proposed system meets the required technical standards and is comparable to leading global satellite broadband networks.
India’s Indigenous LEO Satellite Vision
Under the proposal, Reliance Jio plans to deploy between 1,600 and 1,650 satellites in Low Earth Orbit at an altitude of around 650 kilometres.
The planned constellation is expected to provide high-speed satellite connectivity across India, with approximately 32 satellites visible from any location at a given time. The company aims to roll out the network within the next two to three years, subject to regulatory approvals.
According to industry estimates, the satellite system could deliver 4.5 to 5 terabits per second (Tbps) of total data capacity, making it one of the largest satellite broadband projects proposed in India.
The project is expected to require an investment of $10–15 billion (approximately ₹95,000 crore to ₹1.42 lakh crore), reflecting the scale of infrastructure needed for satellite manufacturing, launches, ground stations, and user terminals.
Regulatory Process Moves Forward
Following the successful technical review, the proposal is expected to move into the next phase of regulatory approvals.
The government may now assist Jio in securing orbital slots, coordinating spectrum usage, and filing applications with the International Telecommunication Union (ITU), the global body responsible for managing satellite orbit and frequency allocations.
Obtaining orbital rights remains a critical step, as Low Earth Orbit has become increasingly competitive due to the growing number of satellite broadband projects being planned worldwide.
Officials also indicated that the proposed satellite architecture has been designed to coexist with future Indian LEO constellations, allowing multiple domestic operators to share orbital resources efficiently.
Broadband, Mobile Connectivity, and Strategic Applications
Jio plans to use the satellite network to provide a range of communication services, including satellite broadband, mobile backhaul, enterprise connectivity, and direct-to-device (D2D) satellite communication, particularly in remote and underserved regions where conventional telecom infrastructure is limited.
The company also intends to establish 20 to 22 ground stations across India to support network operations.
Apart from commercial telecommunications, officials have highlighted the project’s potential strategic importance. A domestically developed satellite constellation could strengthen India’s communication infrastructure, reduce dependence on foreign satellite operators, and support national security requirements.
Reports suggest preliminary discussions are underway regarding the possibility of integrating defence-related payloads into some satellites, enabling both civilian and strategic use.
Major Step for India’s Space and Telecom Sectors
Industry analysts view the technical clearance as an important milestone in India’s expanding private space ecosystem. If Jio secures the remaining regulatory approvals and international orbital clearances, the project could become the country’s first large-scale indigenous LEO satellite broadband network.
The initiative also aligns with India’s broader efforts to expand digital connectivity while strengthening its presence in the global satellite communications market.
Business
Alleged Crores Pharma Scam Mastermind Arrested from Surat
After evading law enforcement for nearly 13 years, an accused linked to a large-scale pharmaceutical fraud case has been arrested by Delhi Police from Surat, Gujarat. The suspect is alleged to have orchestrated a series of financial scams involving fake identities, forged documents, and dishonoured cheques used to procure high-value pharmaceutical raw materials.
Authorities say the accused, identified as Himmat Singh Lodha, is believed to have defrauded multiple pharmaceutical companies in Delhi of goods worth approximately ₹98 lakh before disappearing and remaining underground for years.
Fake Business Deals and Dishonoured Cheques Used in Fraud
Investigators claim the accused posed as a legitimate pharmaceutical trader and placed bulk orders for expensive drug ingredients, offering post-dated cheques as payment security.
In one documented case from 2013, he allegedly obtained around 550 kilograms of Gliclazide, a diabetes-related pharmaceutical ingredient, valued at over ₹26 lakh. When suppliers attempted to encash the cheques, they were reportedly returned with the remark “account closed.”
Following the transaction, the accused allegedly vacated his office and rented residence and disappeared without settling payments. He was later declared a proclaimed offender in 2016 after repeatedly failing to appear before court proceedings. Authorities had also issued a reward for information leading to his arrest.
Multiple Identities and Repeated Fraud Pattern
Police investigations further link the accused to another cheating case dating back to 2012, where he allegedly used a fake identity, “Kailash Jain,” to obtain a large consignment of Ambroxol HCL, a pharmaceutical compound used in cough medications. The value of that consignment was estimated at around ₹72 lakh.
Officials believe the accused followed a consistent modus operandi—posing as a credible businessman, securing high-value goods on deferred payment terms, and then disappearing after delivery while shutting down business operations.
Investigators suspect that forged business records, fake company credentials, and fabricated financial histories were used to build trust with suppliers and gain access to expensive raw materials.
Multi-State Surveillance Leads to Arrest in Surat
A special Crime Branch team tracked the accused through coordinated surveillance efforts across multiple cities, including Mumbai, Ahmedabad, and Surat. After nearly a month of technical monitoring and intelligence gathering, officials located and arrested him from a residential area in Surat.
Authorities also revealed that the accused had been involved in property-related activities while staying under the radar to avoid detection.
Growing Threat of Corporate Identity Fraud
The case highlights a rising trend of organised financial fraud targeting industries that rely heavily on trust-based transactions and deferred payments. Experts note that criminals increasingly exploit gaps in corporate verification systems by using fake GST registrations, temporary offices, and forged documentation to appear legitimate.
Cybercrime and financial fraud specialists warn that such schemes are becoming more complex with the widespread availability of digital business tools, making it easier to create convincing but fraudulent corporate identities.
Experts Urge Stronger Due Diligence in High-Value Transactions
Experts, including former IPS officer and cybercrime specialist Prof. Triveni Singh, emphasize the need for stricter verification procedures in commercial dealings. He noted that relying solely on paperwork or digital business profiles can expose companies to significant financial risk.
Authorities and industry experts recommend physical verification of business operations, bank account validation, and detailed background checks before engaging in high-value or deferred-payment transactions—particularly in sectors like pharmaceuticals, where single consignments can involve transactions worth crores.
Business
EU Pressure Builds on Google as Regulators Face Calls for Massive Fine Over Search Practices
A growing coalition of European industry groups is intensifying pressure on regulators to take decisive action against Google over allegations of unfair search practices that could reshape competition rules across the region’s digital economy.
Investigation Under Digital Markets Act Gains Momentum
The case is being examined by the European Commission under the European Union’s landmark Digital Markets Act (DMA), introduced to curb the dominance of major technology platforms and ensure fair competition.
Launched in March 2024, the investigation focuses on whether Google has been prioritising its own services in search results, potentially disadvantaging rival businesses that rely on online visibility to reach customers.
Industry Groups Demand Swift Action
Several prominent European organizations have jointly urged regulators to conclude the probe without further delay. They argue that prolonged investigations allow alleged anti-competitive practices to continue, putting European companies—especially startups—at a disadvantage.
Signatories include the European Publishers Council, the European Magazine Media Association, the European Tech Alliance, and EU Travel Tech.
In a joint statement, these groups warned that delays in enforcement are affecting innovation, profitability, and growth prospects for regional businesses competing in digital markets.
Google Denies Allegations
Google has rejected claims of bias, stating that its search algorithms are designed to deliver the most relevant and useful results to users. The company has also proposed adjustments to address regulatory concerns.
However, critics argue that these changes are insufficient and fail to address the core issue of market dominance.
Potential Billion-Euro Penalties
If found in violation of the DMA, Google could face significant financial penalties. Under EU rules, fines can reach a substantial percentage of a company’s global turnover, potentially amounting to billions of euros.
Regulators may also impose corrective measures requiring changes to business practices, which could have long-term implications for how digital platforms operate in Europe.
Wider Implications for Big Tech
The case highlights ongoing tensions between European regulators and major U.S. technology firms. In recent years, the EU has taken a more aggressive stance in enforcing competition laws, aiming to create a level playing field for local businesses.
A final ruling against Google could set a major precedent, influencing future enforcement actions and shaping the regulatory landscape for global tech companies operating within Europe.
As scrutiny intensifies, the outcome of the investigation is expected to play a critical role in defining the future of digital competition across the European Union.
-
Business3 years agoPot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business3 years agoNew Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business3 years agoAlabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business3 years agoWashington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business3 years agoMarijuana companies suing US attorney general in federal prohibition challenge
-
Business3 years agoLegal Marijuana Handed A Nothing Burger From NY State
-
Business3 years agoCan Cannabis Help Seasonal Depression
-
Blogs3 years agoCannabis Art Is Flourishing On Etsy
